ShangBay Capital

Profile

ShangBay Capital is a venture capital firm based in Palo Alto, California. Focused on medical device, biotechnology, and healthcare technology sectors, the firm leverages a strong leadership team with over 100 years of cumulative experience. William Dai, the founding managing partner, is recognized among the top growth investors in the healthcare sector. ShangBay Capital differentiates itself by building strong relationships with key opinion leaders, strategics, and innovators to access disruptive technologies addressing high unmet clinical needs.

The firm specifically targets investment opportunities that demonstrate significant clinical benefits and serve unmet needs within the medical device, biopharma, and healthcare segments. It employs a collaborative approach with entrepreneurs, leveraging its comprehensive network to deliver outstanding returns. ShangBay is particularly skilled in navigating the regulatory landscape, assisting portfolio companies to commercialize products, and evaluating market potentials globally. The firm also has a successful record of facilitating companies toward IPOs and acquisitions.

Notable portfolio companies include multiple businesses that have achieved significant milestones such as IPOs and M&As. Named the #1 most active new device VC from 2020 to 2023, their hallmark exits comprise of 13 billion-dollar IPOs among other successful financing events, raising approximately $1 billion across new financings in 2023-2024.